Drugs / ENO Lime
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07140341 | Aug → Sep 2025 | dyspepsia | HALEON | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENO Lime | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07140341 ↗ |
| Route | Oral | “Participants will be instructed to take 1 sachet of ENO Lime powder with approximately 150 milliliters (ml) of normal water as a single dose.” NCT07140341 ↗ |